NasdaqGS - Delayed Quote USD

GeneDx Holdings Corp. (WGS)

21.35 -2.03 (-8.68%)
At close: 4:00 PM EDT
21.13 -0.22 (-1.02%)
After hours: 5:33 PM EDT
Loading Chart for WGS
DELL
  • Previous Close 23.38
  • Open 23.61
  • Bid 21.32 x 100
  • Ask 21.47 x 200
  • Day's Range 21.29 - 23.79
  • 52 Week Range 1.16 - 23.79
  • Volume 485,574
  • Avg. Volume 433,178
  • Market Cap (intraday) 558.322M
  • Beta (5Y Monthly) 2.26
  • PE Ratio (TTM) --
  • EPS (TTM) -4.97
  • Earnings Date Aug 6, 2024 - Aug 12, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 15.25

GeneDx Holdings Corp., through its subsidiaries, provides genomics-related diagnostic and information services. The company offers Centrellis, an AI-driven health intelligence platform that integrates digital tools and artificial intelligence allowing scientists to ingest and synthesize clinical and genomic data to deliver comprehensive health insights. It provides genetic diagnostic tests, screening solutions, and information with a focus on pediatrics, rare diseases for children and adults, and hereditary cancer screening. GeneDx Holdings Corp. was founded in 2017 and is headquartered in Stamford, Connecticut.

www.genedx.com

1,000

Full Time Employees

December 31

Fiscal Year Ends

Recent News: WGS

Performance Overview: WGS

Trailing total returns as of 5/14/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

WGS
676.36%
S&P 500
10.00%

1-Year Return

WGS
210.09%
S&P 500
27.22%

3-Year Return

WGS
94.13%
S&P 500
27.58%

5-Year Return

WGS
--
S&P 500
52.37%

Compare To: WGS

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: WGS

Valuation Measures

Annual
As of 5/13/2024
  • Market Cap

    611.41M

  • Enterprise Value

    616.86M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    2.72

  • Price/Book (mrq)

    2.95

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -60.86%

  • Return on Assets (ttm)

    -16.69%

  • Return on Equity (ttm)

    -50.41%

  • Revenue (ttm)

    221.85M

  • Net Income Avi to Common (ttm)

    -135.02M

  • Diluted EPS (ttm)

    -4.97

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    112.91M

  • Total Debt/Equity (mrq)

    57.12%

  • Levered Free Cash Flow (ttm)

    -106.16M

Research Analysis: WGS

Company Insights: WGS

Research Reports: WGS

People Also Watch